These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35622930)
1. Secukinumab use in the treatment of Netherton's syndrome. Gan C; King E; Orchard D Australas J Dermatol; 2022 Aug; 63(3):365-367. PubMed ID: 35622930 [TBL] [Abstract][Full Text] [Related]
2. [Comel's linear circumflex ichthyosis and Netherton's syndrome. General conceptions based on study of 4 cases (author's transl)]. Dupré A; Bonafé JL; Carrère S Ann Dermatol Venereol; 1978 Jan; 105(1):49-54. PubMed ID: 348004 [TBL] [Abstract][Full Text] [Related]
3. Secukinumab Therapy for Netherton Syndrome. Luchsinger I; Knöpfel N; Theiler M; Bonnet des Claustres M; Barbieux C; Schwieger-Briel A; Brunner C; Donghi D; Buettcher M; Meier-Schiesser B; Hovnanian A; Weibel L JAMA Dermatol; 2020 Aug; 156(8):907-911. PubMed ID: 32459284 [TBL] [Abstract][Full Text] [Related]
4. Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature. Martin-García C; Godoy E; Cabrera A; Cañueto J; Muñoz-Bellido FJ; Perez-Pazos J; Dávila I Int J Immunopathol Pharmacol; 2023; 37():3946320231172881. PubMed ID: 37200480 [TBL] [Abstract][Full Text] [Related]
5. Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature. Özkaya E; Günay MB; Babuna Kobaner G; Keskinkaya Z; Gökalp MO Australas J Dermatol; 2023 May; 64(2):272-277. PubMed ID: 36745433 [TBL] [Abstract][Full Text] [Related]
6. ICHTHYOSIS LINEARIS CIRCUMFLEXA: NOT ALWAYS A PART OF NETHERTON SYNDROME. Bilgili SG; Karadag AS; Calka O; Onder S; Bayram I Genet Couns; 2016; 27(3):353-356. PubMed ID: 30204963 [TBL] [Abstract][Full Text] [Related]